#SubB2M - Twitter Hashtag

about 3 years ago

.@sharecafetweets looks at @INOVIQLtd’s recent developments in our #SubB2M & #EXONET platforms. Read the full article, which details our SubB2M/CA15-3 breast cancer test trial results, & our global marketing partnership with @promega for EXO-NET https://t.co/sU8ABUPiiP #IIQ $IIQ

0

4

1

0

415

INOVIQ Ltd (ASX:IIQ)

@INOVIQLtd

over 3 years ago

.@INOVIQLTD CEO Dr Leearne Hinch recently spoke to @Finnewsnetwork about the excellent clinical results for our #SubB2M CA15-3 #breastcancer test & our global joint marketing agreement with @promega for EXO-NET. https://t.co/3l944AH70h $IIQ #IIQ #diagnostics #EXONET

INOVIQLtd's tweet photo. .@INOVIQLTD CEO Dr Leearne Hinch recently spoke to @Finnewsnetwork about the excellent clinical results for our #SubB2M CA15-3 #breastcancer test & our global joint marketing agreement with @promega for EXO-NET. https://t.co/3l944AH70h $IIQ #IIQ #diagnostics #EXONET https://t.co/i2SkgbiSVk

0

6

2

0

357

INOVIQ Ltd (ASX:IIQ)

@INOVIQLtd

over 3 years ago

.@INOVIQLtd has released a recording of our Investor Webinar briefing, which we held following the release of outstanding clinical data for our SubB2M/CA15-3 test for breast cancer monitoring. Watch here: https://t.co/A7HuvYBqwk $IIQ #SubB2M #breastcancer #diagnostics

INOVIQLtd's tweet photo. .@INOVIQLtd has released a recording of our Investor Webinar briefing, which we held following the release of outstanding clinical data for our SubB2M/CA15-3 test for breast cancer monitoring. Watch here: https://t.co/A7HuvYBqwk
$IIQ #SubB2M #breastcancer #diagnostics https://t.co/shdUqd08mF

0

5

1

0

111

INOVIQ Ltd (ASX:IIQ)

@INOVIQLtd

over 3 years ago

Please join our investor briefing this Thurs at 11am AEST. We’ll discuss how $IIQ SubB2M/CA15-3 breast cancer test was shown to outperform a leading CA15-3 test used routinely in breast cancer monitoring. Register: https://t.co/gypxYBpgrY #diagnostics #SubB2M #breastcancer

INOVIQLtd's tweet photo. Please join our investor briefing this Thurs at 11am AEST. We’ll discuss how $IIQ SubB2M/CA15-3 breast cancer test was shown to outperform a leading CA15-3 test used routinely in breast cancer monitoring. Register: https://t.co/gypxYBpgrY
#diagnostics #SubB2M #breastcancer https://t.co/JiQyPQo9cL

0

2

0

1

694

INOVIQ Ltd (ASX:IIQ)

@INOVIQLtd

over 3 years ago

.@INOVIQLtd has been featured in today's @Finnewsnetwork's Stocks of the Hour $IIQ #breastcancer #SubB2M https://t.co/T9G9098ASt

0

2

0

88

INOVIQ Ltd (ASX:IIQ)

@INOVIQLtd

over 3 years ago

Huge news for $IIQ today, with our SubB2M/CA15-3 test outperforming a leading CA15-3 test, routinely used for breast cancer monitoring in our 483 sample study! Read more: https://t.co/zFUPcWSKIB #diagnostics #SubB2M #breastcancer #oncology

INOVIQLtd's tweet photo. Huge news for $IIQ today, with our SubB2M/CA15-3 test outperforming a leading CA15-3 test, routinely used for breast cancer monitoring in our 483 sample study! Read more: https://t.co/zFUPcWSKIB
#diagnostics #SubB2M #breastcancer #oncology https://t.co/NBChLS1o7K

0

2

0

173

LallaM @lallam

over 6 years ago

@SiennaCancerDx is at it again, increasing our #hTERT #IVD footprint in Europe with the appointment of #Aenorasis as exclusive distributor for all future and current Sienna products including #SIEN-NET and #SubB2M. #globalexpansion #biotechnology #SDX #cytology #greece

lallam's tweet photo. @SiennaCancerDx is at it again, increasing our #hTERT #IVD footprint in Europe with the appointment of #Aenorasis as exclusive distributor for all future and current Sienna products including #SIEN-NET and #SubB2M.

#globalexpansion #biotechnology #SDX #cytology #greece https://t.co/Lc4oVG1mEi

1

2

0

Top Tweets for #SubB2M

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users